Experts analyze the unique biomechanical risks for traumatic brain injury in winter sports following high-profile incidents at the 2026 Winter Olympics.

Desmoda oral solution is now FDA-approved for central diabetes insipidus, allowing clinicians to tailor dosing to individual water balance patterns.

Traumatic brain injury is associated with a significantly higher risk for post-traumatic stress disorder and suicidality compared with orthopedic trauma.

Stereotactic radiation may improve symptoms and reduce interference with daily functioning for patients with multiple brain metastases.

Higher functional independence scores correlate with a greater likelihood of returning home after inpatient traumatic brain injury care.

A new model may help identify neurogenic bladder and other complications in patients with spinal cord injuries.

Individuals with IPV-related head injuries report significantly worse psychiatric and cognitive outcomes than those with IPV exposure alone.

Low-dose opioid therapy provides stable, long-term symptom control and dose stability for patients with augmented restless legs syndrome.

A blood test measuring plasma %p-tau217 levels accurately predicts the age of Alzheimer disease symptom onset.

Exposure to air pollution and fine particulate matter appears to be directly associated with an increased risk for Alzheimer disease.

FDA grants Breakthrough Therapy designation to luvesilocin for postpartum depression following positive results from the phase 2 RECONNECT trial.

A retrospective study shows a synergistic interaction between Parkinson disease and stroke, leading to increased long-term mortality risk.